Raymond James Financial »

Lucid Diagnostics shares owned by Raymond James Financial

Quarter-by-quarter ownership of Lucid Diagnostics (LUCD) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Lucid Diagnostics

Tip: Access up to 7 years of quarterly data

All positions including Lucid Diagnostics held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lucid Diagnostics by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $604k 525k 1.15
2025-06-30 $910 791 1.15

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p500 Etf (IVV)
Johnson & Johnson (JNJ)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Lucid Diagnostics

BlackRock
Vanguard Capital Management
Masters Capital Mgmt
Standard Life Aberdeen
Two Seas Capital
Geode Capital Management
Russell Investments
State Street Corporation
Wells Fargo & Company
Perkins Capital Management
Sunbelt Securities
Northern Trust
Vanguard Fiduciary Trust
Vanguard Portfolio Management
Raymond James Financial

View all funds holding Lucid Diagnostics